These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3754099)

  • 21. A problem with atracurium.
    Duncan PW
    Anaesthesia; 1983 Jun; 38(6):597. PubMed ID: 6688157
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuromuscular blocking action of atracurium in the dog and its reversal by neostigmine.
    Jones RS; Hunter JM; Utting JE
    Res Vet Sci; 1983 Mar; 34(2):173-6. PubMed ID: 6687951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
    Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
    Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Edrophonium priming for antagonism of atracurium neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Can J Anaesth; 1990 Mar; 37(2):197-201. PubMed ID: 2311149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary assessment of atracurium, a new competitive neuromuscular blocking agent.
    Coker GG; Dewar GH; Hughes R; Hunt TM; Payne JP; Stenlake JB; Waigh RD
    Acta Anaesthesiol Scand; 1981 Feb; 25(1):67-9. PubMed ID: 7293706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of two levels of partial neuromuscular block with atracurium on the ventilatory response to hypercapnia in anesthetized Beagles.
    Sakai DM; Martin-Flores M
    Am J Vet Res; 2018 Sep; 79(9):915-920. PubMed ID: 30153055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.
    Naguib M
    Can J Anaesth; 1989 Jan; 36(1):25-9. PubMed ID: 2644050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anesthesia and the Lesch-Nyhan syndrome.
    Larson LO; Wilkins RG
    Anesthesiology; 1985 Aug; 63(2):197-9. PubMed ID: 3839638
    [No Abstract]   [Full Text] [Related]  

  • 33. Recovery of respiration following neuromuscular blockade with atracurium and alcuronium.
    Astley BA; Hackett H; Hughes R; Payne JP
    Br J Anaesth; 1986; 58 Suppl 1():75S-79S. PubMed ID: 3754758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
    Martin-Flores M; Boesch J; Campoy L; Gleed RD
    J Am Anim Hosp Assoc; 2011; 47(4):294-8. PubMed ID: 21673340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromuscular and cardiovascular effects of atracurium administered to healthy horses anesthetized with halothane.
    Hildebrand SV; Arpin D
    Am J Vet Res; 1988 Jul; 49(7):1066-71. PubMed ID: 3421529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated reversal of atracurium blockade with priming doses of edrophonium.
    Naguib M; Abdulatif M; Absood GH
    Anesthesiology; 1987 Mar; 66(3):397-400. PubMed ID: 3030160
    [No Abstract]   [Full Text] [Related]  

  • 37. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracurium-induced neuromuscular blockade.
    Kopman AF
    Anesthesiology; 1991 Oct; 75(4):588-93. PubMed ID: 1681762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electromyographic assessment of neuromuscular blockade induced by atracurium.
    Calvey TN; Macmillan RR; West DM; Williams NE
    Br J Anaesth; 1983; 55 Suppl 1():57S-62S. PubMed ID: 6305381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular and cardiovascular effects of atracurium in ponies anesthetized with halothane.
    Hildebrand SV; Howitt GA; Arpin D
    Am J Vet Res; 1986 May; 47(5):1096-100. PubMed ID: 3755016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.